Cutia Therapeutics (HK:2487) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cutia Therapeutics’ CEO, Ms. Zhang Lele, has further increased her stake in the company by purchasing an additional 5,000 shares, reflecting her strong confidence in its future growth. This brings her total recent acquisitions to 33,000 shares, amounting to approximately HK$393,212. Her actions underscore a positive outlook for the company’s market potential and business prospects.
For further insights into HK:2487 stock, check out TipRanks’ Stock Analysis page.